meeting, page-25

Let me say this much. I'm not very happy that my company's management used my invested capital to buy up a 16 plus percent share in Avexa, with over a million shares that roll right down to me. I think that those AVX investors who are still emotionally attached to the notion of developing and marketing a new AIDS drug are now a drag on the company and its prospects for the future. The sooner that this ship can cast off the anchor, the sooner she can be engaged on a new journey. Conversely the longer she remains enamored of this charity case, the worse off all investors will be including me. I wish I could sell, but only my board can do that. They have already heard from me and they will continue to hear from me until either they use their position to put AVX on a sane and potentially profitable path or get out of Dodge entirely and leave her to her fate.